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Macrophage Infiltration of Tumor Cell Islets Predicts Good 
Prognosis of Lung Cancer
Liu, Lun Xu; Yu, Nan Bin 
Dept. of Thoracic Surgery,West China Hospital,Sichuan University, 
Chengdu, China
Many studies have suggested that the immune inﬁltrate may beneﬁt 
the tumor by producing a pro-tumor microenvironment.The aim of this 
study is to investigate the macrophage inﬁltration in lung cancer and 
benign lesions, and to evaluate its correlation with cancer prognosis.
Methods: Surgically rescected 146 cases of lung cancer and 20 cases 
of benign lesions were examined by immunohistochemical SP method 
using monoclonal antibody to CD68. Statistical analyses were carried 
out using SPSS13.0.
Results: 
(1) Macrophage counts in tumor stromal and islets in lung cancer were 
signiﬁcantly lower than those in benign lesions (p<0.05); Macro-
phage counts in tumor islets were signiﬁcantly lower than those in 
tumor stroma (p<0.05).
(2) Tumor islets macrophage counts and Tumor islets/stromal mac-
rophage ratio were both inversely correlated with tumor stages; 
Tumor stromal macrophage counts were positively correlated with 
tumor stages; Tumour islets macrophage counts in patients with 
lymph node metastasis were lower than those without lymph node 
metastasis(P<0.05). Tumor stromal macrophage counts in patients 
with lymph node metastasis were higher than those without lymph 
node metastasis(p>0.05).
(3) Tumor islets macrophage counts and tumor islet/stromal macro-
phage ratio were positively correlated with patient survival time 
(P<0.001); Tumor stromal macrophage counts were inversely cor-
related with patient survival time (P<0.01).
(4) Tumor islet macrophage counts and tumor islet/stromal macrophage 
ratio were favorable independent prognostic indicators(p<0.05);In 
contrast, tumor stromal macrophage count was an independent 
predictor of reduced survival(p<0.05).
Conclusions: 
(1) Tumor islet macrophage count and tumor islet/stromal macrophage 
ratio are powerful predictors of survival in lung cancer;This has 
important implications for adjuvant therapy after resection of lung 
cancer.
(2) Macrophage inﬁltrated within tumor of lung cancer may have dual 
functions. Macrophages entered tumor islets may have anti-tumor 
immune response; but those remained in stroma may potentially 
promote progression and metastasis of cancer.
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Expression of CN-II in non-small cell lung cancer and its clinical 
significance
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Xiaoling2 Li, Xiaobing2 Liu, Guangxian2 
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Background: Cytosolic 5-nucleotidase(CN-II), a nucleotide kinase, 
possesses both 5-nucleotidase and nucleoside phosphotransferase 
activities. Abnormal expression of CN-II may be correlated with 
resistance to nucleoside analogues anticancer drugs. This study was de-
signed to investigate the expression of CN-II in human non-small cell 
lung cancer (NSCLC) tissues and its correlation to clinic pathological 
parameters as well as prognosis in patients treated with gemcitabine. 
Methods: Expression of CN-II was detected in 70 cases of parafﬁn 
embedded NSCLC samples by immunohistochemistry. Its correlations 
to clinic pathological parameters as well as response to gemcitabine 
chemotherapy were analyzed using chi-square test. Log-ranl test was 
used to check wether CN-II expression was correlated with patients’ 
overall survival (OS). 
Results: The positive rate of CN-II in 70 non-small cell lung cancer tis-
sues were 52.9%. There was no signiﬁcant relationship between CN-II 
expression and clinic pathological parameters. Among 21 patients who 
had received gemcitabine chemotherapy, those with tumor progressed 
(positive rate 83.3%) had higher CN-II expression than the patients 
with efﬁcacious (positive rate16.7%, P<0.05) and disease control che-
motherapy (positive rate33.3%, P<0.05). Patients with positive CN-II 
expression had signiﬁcant better OS than negative (P<0.05). 
Conclusion: Over expression of CN-II maybe correlated with resis-
tance to gemcitabine. CN-II may be an independent prognostic factor 
for response and total survival time for patients with gemcitabine 
chemotherapy. 
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Increased expression levels of human telomerase reverse 
transcriptase (hTERT) mRNA correlates with poor prognosis in 
resected non small cell lung cancer (NSCLC) patients
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Martínez, Begoña2 Aresti, Unai2 Jangi, Muhialdin S.2 Gil-Negrete-
Laborda, Aitziber1 Ancizar Lizarraga, Nerea1 
1 Medical Oncology Department, Hospital Cruces, Barakalado, Spain 2 
Molecular Biology Laboratory, Investigational Unit, Hospital Cruces, 
Barakalado, Spain 
Background: Lung cancer is the leading cause death worldwide. 
NSCLC accounts for approximately 80% of all lung tumors. Telom-
erase adds hexameric TTAGGG nucleotide repeats onto the ends of 
chromosomal DNAs to compensate for losses of each cell replication. 
Correlation between telomerase level expression, clinico-pathological 
characteristics and survival of lung cancer is not well established in 
NSCLC.
Methods: We studied 149 consecutive patients (140 men/9 women) 
with resected NSCLC: 37.6% adenocarcinoma, 59 % squamous cell, 
and 3.4% large cell carcinoma. Pathological stage: I (36.9%), II (32.3%) 
and III (30.8%). Reverse transcription-polymerase chain reaction (RT-
PCR) analysis was used for the detection hTERT expression in lung 
cancer tissues immediately snap-frozen in liquid nitrogen at -80 ºC.
Results: Median and mean values of hTERT mRNA were 18.27 and 
475.29 (SE 309.76). There were no signiﬁcant differences on expres-
sion according to sex, histology, smoking history and pathological 
stage (ANOVA). Patients with highest values of hTERT mRNA expres-
sion (percentile 95, cut-off value >353) had worse median progression 
free survival (PFS) (p=0.024) and overall survival (OS) (p=0.020), 
using Kaplan-Meier method. Multivariate analysis by Cox regression 
yielded that hTERT level > 353 independently predicted a worse PFS 
